SLNO

Q: What is the price of Soleno Therapeutics (SLNO) today?

The price of Soleno Therapeutics (SLNO) today is $ 39.49, with return of -41.48% compared to the last year. The price of Soleno Therapeutics (SLNO) started the year trading around $ 46.30 and today it is at $ 39.49. Follow the real-time price chart, the historical price of Soleno Therapeutics (SLNO) and international markets.

Q: When does Soleno Therapeutics (SLNO) pay dividends?

Soleno Therapeutics (SLNO) did not distribute dividends in the last year.

Q: Is Soleno Therapeutics (SLNO) worth it?

Currently, Soleno Therapeutics (SLNO) is priced at $ 39.49, with a P/E of 100.19%, representing a deviation of 1,379% from its historical average P/E. In the last year, the stock showed a variation of -41.48 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -41.48%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Soleno Therapeutics (SLNO) stock?

Investing in stocks of Soleno Therapeutics (SLNO) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Soleno Therapeutics (SLNO) yield today?

The yield of Soleno Therapeutics (SLNO) was 2.39% in the last month, -41.48% in the last year and 115.79% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Soleno Therapeutics (SLNO) today, the total investment would be $ 3,949.00, based on the current price of $ 39.49.If past performance were to repeat, the return on your investment would be:In 1 year: $ 2,310.95In 5 years: $ 8,521.55In 10 years: $ 1,732.82It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Soleno Therapeutics Inc.

Price

$ 39.49

return (12m)

-41.48%

p/e

100.19

p/bv

4.65

DIVIDEND YIELD

0.00%

SLNO price

SLNO

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment SLNO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.39%

3 months

-16.28%

1 year

-41.48%

2 years

-4.36%

5 years

115.79%

10 years

-56.12%

Fundamentals SLNO

review the fundamentals of Soleno Therapeutics shares

P/E

100.19

Sector: -5.82 Industry: -5.82

P/S (PSR)

10.99

Sector: -4.74 Industry: -4.74

P/BV

4.65

Sector: 1.40 Industry: 1.40

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

3.71%

Sector: -72.38% Industry: -72.38%

ROE

4.64%

Sector: -84.15% Industry: -84.15%

ROIC

95.58%

Sector: -1,194.38% Industry: -1,194.38%

NET MARGIN

10.97%

Sector: -46.16% Industry: -46.16%

GROSS MARGIN

98.58%

Sector: 35.92% Industry: 35.92%

OPERATING MARGIN

7.85%

Sector: -46.05% Industry: -46.05%

EV/EBITDA

75.04

Sector: -5.52 Industry: -5.52

EV/EBIT

79.37

Sector: -5.77 Industry: -5.77

PRICE-TO-ASSETS

3.71

Sector: 1.13 Industry: 1.13

BVPS

8.49

Sector: 1.63 Industry: 1.63

EPS

0.39

Sector: -2.73 Industry: -2.73

EQUITY-TO-ASSETS RATIO

0.80

Sector: 0.32 Industry: 0.32

LIABILITIES / ASSETS

0.20

Sector: 0.33 Industry: 0.33

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF Soleno Therapeutics ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 39.49

Fair Value

$ 0.00

Upside/Downside Return potential.

-78.14%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals SLNO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.84	7.39	33.81%	2.14%	$ 585.48 B	28.46%
PFE	20.72	1.73	8.35%	6.07%	$ 161.03 B	12.42%
ABBV	87.32	0.00	0.00%	3.18%	$ 369.02 B	6.91%
NVO	10.48	5.40	51.50%	4.56%	$ 164.23 B	33.05%
MRK	16.43	0.00	0.00%	2.71%	$ 300.00 B	28.08%
AZN	30.87	6.48	20.99%	1.57%	$ 315.61 B	17.41%
GILD	20.39	7.67	37.62%	2.28%	$ 173.52 B	28.90%
BMY	17.20	-3.56	-20.72%	4.18%	$ 121.35 B	14.64%
ZTS	19.33	15.51	80.25%	1.72%	$ 51.66 B	28.23%
REGN	17.42	2.51	14.41%	0.47%	$ 78.47 B	31.41%
HALO	24.01	155.91	649.21%	0.00%	$ 7.61 B	22.69%
AMGN	24.32	21.66	89.06%	2.78%	$ 187.54 B	20.98%
MCK	25.06	-1,098.65	-4,383.84%	0.36%	$ 108.77 B	1.09%
VRTX	28.19	5.97	21.18%	0.00%	$ 111.43 B	32.94%
CAH	30.39	-18.71	-61.56%	0.95%	$ 50.52 B	0.68%
ADMA	14.89	4.58	30.78%	0.00%	$ 2.19 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%
HRMY	9.96	1.82	18.24%	0.00%	$ 1.58 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

SLNO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Soleno Therapeutics

Soleno Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

27 years

Founded: 1999

2014

Time since IPO - 12 years

31

Employees

The Company Soleno Therapeutics Inc. (United States), is listed on Nasdaq with a market value of $ 2.09 Billions, having an equity of $ 450.12 Millions.

With a total of 31 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 190.41 Millions, which generated a profit in the amount of $ 20.89 Millions.

As for its main indicators, the Company has a P/E ratio of 100.19, a P/BV ratio of 4.65 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker SLNO.

Market cap

$ 2.09 Billions

Net worth

$ 450.12 Millions

US$ 450,120,000.00

Assets

$ 563.83 Millions

US$ 563,830,000.00

Total Shares Outstanding

53.00 Millions

53,000,000

Average Daily Trading Volume

$ 1.65 Million

US$ 1,647,482.74

Sector

Health Care

Industry

Biotechnology

SLNO

SLNO revenue and profits

Financial Results SLNO

DRAG THE FRAME TO SEE MORE DATA

SLNO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 884.28 29,96% (12M)

P/E

25.06

0.36%

ROE

-4,383.84%

P/BV

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12M)

P/E

21.84

2.14%

ROE

33.81%

P/BV

7.39

PFE - Pfizer

$ 28.32 32,24% (12M)

P/E

20.72

6.07%

ROE

8.35%

P/BV

1.73

ABBV - AbbVie

$ 208.84 16,32% (12M)

P/E

87.32

3.18%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12M)

P/E

16.43

2.71%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12M)

P/E

30.87

1.57%

ROE

20.99%

P/BV

6.48

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 884.28 29,96% (12 M)

P/L

25.06

0.36%

ROE

-4,383.84%

P/VP

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12 M)

P/L

21.84

2.14%

ROE

33.81%

P/VP

7.39

PFE - Pfizer

$ 28.32 32,24% (12 M)

P/L

20.72

6.07%

ROE

8.35%

P/VP

1.73

ABBV - AbbVie

$ 208.84 16,32% (12 M)

P/L

87.32

3.18%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12 M)

P/L

16.43

2.71%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12 M)

P/L

30.87

1.57%

ROE

20.99%

P/VP

6.48

Frequently Asked Questions

What is the price of Soleno Therapeutics (SLNO) today?

The price of Soleno Therapeutics (SLNO) today is $ 39.49, with return of -41.48% compared to the last year. The price of Soleno Therapeutics (SLNO) started the year trading around $ 46.30 and today it is at $ 39.49. Follow the real-time price chart, the historical price of Soleno Therapeutics (SLNO) and international markets.

When does Soleno Therapeutics (SLNO) pay dividends?

Soleno Therapeutics (SLNO) did not distribute dividends in the last year.

Is Soleno Therapeutics (SLNO) worth it?

Currently, Soleno Therapeutics (SLNO) is priced at $ 39.49, with a P/E of 100.19%, representing a deviation of 1,379% from its historical average P/E. In the last year, the stock showed a variation of -41.48 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -41.48%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Soleno Therapeutics (SLNO) stock?

Investing in stocks of Soleno Therapeutics (SLNO) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Soleno Therapeutics (SLNO) yield today?

The yield of Soleno Therapeutics (SLNO) was 2.39% in the last month, -41.48% in the last year and 115.79% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Soleno Therapeutics (SLNO) today, the total investment would be $ 3,949.00, based on the current price of $ 39.49.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 2,310.95
In 5 years: $ 8,521.55
In 10 years: $ 1,732.82

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

SLNO

Soleno Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SLNO

review the fundamentals of Soleno Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Soleno Therapeutics

Soleno Therapeutics Inc.

United States

27 years

2014

31

PROFIT X PRICE SLNO

Financial Results SLNO

SLNO cash flow

Asset, Revenue and Profit Growth - SLNO

SLNO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions